IL22 and colitis: AhR antagonist completely abolished the ameliorating effects of XANA on colitis, including body weight, DAI, colon length, colon histology, and serum levels of IL‐1β, IL‐6, TNF‐α, IL‐4, IL‐10, and IL‐22 (Figure7A–O).